Microbix Biosystems (MBX) Competitors C$0.27 0.00 (0.00%) As of 02:14 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock MBX vs. SCYB, COM, NVH, IGX, MDNA, PDP, SVA, COV, EMH, and PMNShould you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Pediapharm (PDP), Sernova (SVA), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), and ProMIS Neurosciences (PMN). These companies are all part of the "biotechnology" industry. Microbix Biosystems vs. Its Competitors Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Pediapharm Sernova Covalon Technologies Emerald Health Therapeutics ProMIS Neurosciences Scythian Biosciences (CVE:SCYB) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Is SCYB or MBX more profitable? Microbix Biosystems has a net margin of 13.86% compared to Scythian Biosciences' net margin of 0.00%. Microbix Biosystems' return on equity of 12.65% beat Scythian Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Scythian BiosciencesN/A N/A N/A Microbix Biosystems 13.86%12.65%3.82% Do insiders and institutionals have more ownership in SCYB or MBX? 0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better earnings & valuation, SCYB or MBX? Microbix Biosystems has higher revenue and earnings than Scythian Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScythian BiosciencesN/AN/AN/AN/AN/AMicrobix BiosystemsC$21.13M1.79C$3.39M-C$0.00-135.00 Does the media favor SCYB or MBX? In the previous week, Scythian Biosciences' average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score. Company Overall Sentiment Scythian Biosciences Neutral Microbix Biosystems Neutral SummaryMicrobix Biosystems beats Scythian Biosciences on 6 of the 6 factors compared between the two stocks. Get Microbix Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$37.87MC$222.70MC$6.02BC$9.69BDividend Yield2.30%3.81%5.73%6.52%P/E Ratio-135.0098.9685.1229.75Price / Sales1.795,693.57589.7013.29Price / Cash4.1313.1925.7783.29Price / Book1.31106.1212.675.88Net IncomeC$3.39M-C$90.99MC$3.32BC$301.20M7 Day Performance3.85%-0.28%0.49%0.57%1 Month Performance14.89%4.24%9.41%7.17%1 Year Performance-19.40%736.30%79.11%43.53% Microbix Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMicrobix BiosystemsN/AC$0.27flatN/A-20.6%C$37.87MC$21.13M-135.00N/ASCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$0.93+1.1%N/A-57.8%C$77.57MN/A-5.8120PDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/ASVASernovaN/AC$0.18-2.7%N/A-34.6%C$59.16MN/A-3.601,959Gap UpCOVCovalon TechnologiesN/AC$2.05-0.5%N/A-39.8%C$56.21MC$32.99M22.78N/AEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161News CoveragePMNProMIS NeurosciencesN/AN/AN/AN/AC$51.48MC$7.56K-1.786Gap UpHigh Trading Volume Related Companies and Tools Related Companies Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Medicenna Therapeutics Competitors Pediapharm Competitors Sernova Competitors Covalon Technologies Competitors Emerald Health Therapeutics Competitors ProMIS Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:MBX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
